Search Within

Marc Ladanyi

  1. "Adam Schoenfeld"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (12)
Groups
  1. Department of Medicine (36)
  2. Department of Pathology and Laboratory Medicine (36)
  3. GSK Faculty (36)
  4. Hematologic Malignancies, Division of (36)
  5. Hematology-Oncology Fellows (36)
  6. Human Oncology and Pathogenesis Program (36)

More Groups

People
  1. Adam Schoenfeld (36)
  2. Gregory Riely (26)
  3. Charles Rudin (17)
  4. Hira Rizvi (16)
  5. Mark Kris (16)
  6. Maria Arcila (14)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (9)
  4. 2022 (4)
  5. 2021 (2)
  6. 2020 (8)

More Years

Publications
  1. Journal of Thoracic Oncology (10)
  2. Journal of Clinical Oncology (7)
  3. Clinical Cancer Research (6)
  4. Annals of Oncology (3)
  5. JCO Precision Oncology (2)
  6. Cancer Research (1)

More Publications

Publishers
  1. Elsevier Inc. (10)
  2. American Society of Clinical Oncology (9)
  3. American Association for Cancer Research (8)
  4. Oxford University Press (4)
  5. American Medical Association (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (36)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
    Journal Article

    Zucker, M.; Perry, M. A.; Gould, S. I.; Elkrief, A.; Safonov, A.; Thummalapalli, R.; Mehine, M.; Chakravarty, D.; Brannon, A. R.; Ladanyi, M.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
    Journal Article

    Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer
    Journal Article

    Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
    Journal Article

    Elkrief, A.; Méndez-Salazar, E. O.; Maillou, J.; Vanderbilt, C. M.; Gogia, P.; Desilets, A.; Messaoudene, M.; Kelly, D.; Ladanyi, M.; Hellmann, M. D.; more...
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and recurrent somatic MLH1 inactivation
    Journal Article

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D. A.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benayed, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer
    Journal Article

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Impact of aneuploidy and chromosome 9p loss on tumor immune microenvironment and immune checkpoint inhibitor efficacy in NSCLC
    Journal Article

    Alessi, J. V.; Wang, X.; Elkrief, A.; Ricciuti, B.; Li, Y. Y.; Gupta, H.; Spurr, L. F.; Rizvi, H.; Luo, J.; Pecci, F.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Luo, J.; Alessi, J. V. M.; Pecci, F.; Lamberti, G.; Hong, Lingzhi; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer
    Meeting Abstract

    Mukherjee, S.; Schroeder, A.; Chatterjee, S.; Cadley, J.; Falcon, C. J.; Mehine, M.; Bandlamudi, C.; Chatterjee, A.; Ladanyi, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save